Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

Rhea-AI Summary

Teknova (Nasdaq: TKNO), a leading producer of critical reagents for therapy, vaccine, and molecular diagnostics development, has scheduled its first quarter 2025 financial results announcement for May 8, 2025, after market close. The company will host a webcast and conference call at 5 p.m. Eastern Time on the same day. Interested participants can access the webcast through Teknova's Investor Relations section and must register to receive a unique PIN for dial-in access. A replay will be available on the company's website approximately two hours after the event.

News Market Reaction

-2.41%

1 alert

-2.41% News Effect

On the day this news was published, TKNO declined 2.41%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, following the close of market.

Teknova will host a webcast and conference call on Thursday, May 8, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.

Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100 

Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259

This press release was published by a CLEAR® Verified individual.

FAQ

When will Teknova (TKNO) release Q1 2025 earnings?

Teknova will release Q1 2025 earnings on May 8, 2025, after market close.

How can investors join Teknova's (TKNO) Q1 2025 earnings call?

Investors can join via webcast through Teknova's Investor Relations section or register online to receive a unique PIN for dial-in access.

What time is Teknova's (TKNO) Q1 2025 earnings call?

The earnings call is scheduled for 5 p.m. Eastern Time on May 8, 2025.

Will there be a replay available for Teknova's (TKNO) Q1 2025 earnings call?

Yes, a replay will be available on Teknova's website approximately two hours after the event.